Showing results (311-320 of 394) with videos related to
Sort By:
Pageof 40
The Journal of Pathology|August 9, 2005
Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel diseaseI Szanto, L Rubbia-Brandt, P Kiss, et al.American Journal of Clinical Oncology|January 1, 1991
Clinical effects of recombinant human interleukin-3A Ganser, A Lindemann, G Seipelt, et al.European Journal of Biochemistry|December 15, 1993
Equine infectious anemia virus Tat is a predominantly helical proteinH Sticht, D Willbold, P Bayer, et al.Molecular and Cellular Biology|July 1, 1996
The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteinsR R Schumann, C J Kirschning, A Unbehaun, et al.Endoscopy International Open|April 21, 2021
Functional endoscopy in neurogenic dysphagia: a feasibility study focusing on the esophageal phase of swallowingJan Rückert, Philipp Lenz, Hauke Heinzow, et al.Blood|May 15, 1992
Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I studyA Ganser, A Lindemann, O G Ottmann, et al.British Journal of Cancer|June 1, 1995
Is neuroblastoma screening evaluation needed and feasible?J Estève, L Parker, P Roy, et al.Medical and Pediatric Oncology|January 1, 1994
High-dose consolidation with local radiation and bone marrow rescue in patients with advanced neuroblastomaB Kremens, T Klingebiel, F Herrmann, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1991
Recombinant human interleukin-3 in patients with hematopoietic failureA Ganser, A Lindemann, G Seipelt, et al.Blood|August 15, 1990
Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failureA Ganser, A Lindemann, G Seipelt, et al.Pageof 40